Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Patient reported symptoms associated with quality of life during chemo- or immunotherapy for bladder cancer patients with advanced disease

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Impact of meningioma surgery on use of antiepileptic, antidepressant, and sedative drugs: A Swedish nationwide matched cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Bladder cancer (BC) patients with advanced disease have poor outcomes. The use of patient-reported outcomes (PROs) could lead to improvements in symptom management and hence quality of life (QoL). The aim of this study is to report correlations between selected PROs and QoL and thus to present symptoms that influence QoL. Identification of these symptoms during treatment can lead to earlier symptom management and thus secure improvements in QoL.

METHODS: BC patients in chemo- or immunotherapy for locally advanced or metastatic disease reported weekly PROs for the duration of their treatment. The PROs included EORTC QLQ-C30 and QLQ-BLM30 and 45 selected PRO-CTCAE items. Spearman's correlation analysis was performed for all PRO-CTCAE items and QLQ-C30 global QoL and subdomains.

RESULTS: In this study, 78 BC patients reported 724 questionnaires. Spearman's analysis showed significant correlations between almost all PRO-CTCAE items and the expected domain of QoL. The PRO-CTCAE items with the strongest correlations with QoL were anxiety (F, frequency item) and emotional function (rs = -0.603, P < .0001), concentration (S, severity item) and cognitive function (rs = -0.704, P < .0001), discouraged (F) and emotional function (rs = -0.659, P < .0001), fatigue (S) and role function (rs = -0.659, P < .0001) and sad (F) and emotional function (rs = -0.711, P < .0001). The weakest correlations were found for the PRO-CTCAE items urinary frequency, incontinence and urge, all with variations in the direction and significance of the correlations.

CONCLUSIONS: This study delivers information on which PROs may influence QoL for patients in clinical trials or daily clinic. Psychological issues have a strong impact on QoL and should be dealt with during treatment to secure the best possible QoL for BC patients.

Original languageEnglish
JournalCancer Medicine
Issue number9
Pages (from-to)3078-3087
Number of pages10
Publication statusPublished - May 2020

Bibliographical note

Publisher Copyright:
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Copyright 2020 Elsevier B.V., All rights reserved.

    Research areas

  • chemotherapy, immunotherapy, Patient-reported outcomes, quality of life, urinary bladder neoplasms

ID: 60921488